Trials / Not Yet Recruiting
Not Yet RecruitingNCT07245316
Avoiding Surgery in Estrogen Receptor Positive Atypical Ductal Hyperplasia and In-situ Carcinoma Treated With Endocrine Treatment Trial
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 340 (estimated)
- Sponsor
- Jeong Eon Lee · Academic / Other
- Sex
- Female
- Age
- 35 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the 5-year invasive ipsilateral breast cancer incidence rate in patients with hormone-receptor positive, HER-2 negative atypical ductal hyperplasia or in-situ carcimona who omitted surgery and received endocrine therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Avoiding surgery | Avoiding surgery in hormone-receptor positive atypical ductal hyperplasia and in-situ carcinoma treated with endocrine treatment |
Timeline
- Start date
- 2025-12-01
- Primary completion
- 2032-12-31
- Completion
- 2032-12-31
- First posted
- 2025-11-24
- Last updated
- 2025-11-24
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07245316. Inclusion in this directory is not an endorsement.